Evidence map›Paper›PMID 37197070›Full record

ArticleIranian journal of parasitology

Synthesis and Clinical Examination of Novel Formulations of Ivermectin, Albendazole and Niclosamide for the Treatment of Equine Gastrointestinal Helminthoses.

Victor Alexeevich Marchenko, Salavat Samadovich Khalikov, Ivan Vladimirovich Biryukov, Elena Alexandrovna Efremova, Mikhail Mikhailovich Ilyin, Alireza Sazmand

Open access · goldAbstract read
In one paragraph

Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Victor Alexeevich MarchenkoFederal Altai Scientific Center for Agrobiotechnology, Town 35, Barnaul, Russia.
Salavat Samadovich KhalikovA.N. Nesmeyanov Institute of Organoelement Compounds Russian Academy of Science, Moscow, Russia.
Ivan Vladimirovich BiryukovFederal Altai Scientific Center for Agrobiotechnology, Town 35, Barnaul, Russia.
Elena Alexandrovna EfremovaSiberian Federal Scientific Centre of Agro-Bio Technologies RAS, Krasnoobsk, Russia.
Mikhail Mikhailovich IlyinA.N. Nesmeyanov Institute of Organoelement Compounds Russian Academy of Science, Moscow, Russia.
Alireza SazmandDepartment of Pathobiology, Faculty of Veterinary Science, Bu-Ali Sina University, 6517658978 Hamedan, Iran.
Altai Scientific Research Institute of Machine Building Technology · RUBu-Ali Sina University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed to develop new complex preparations of ivermectin, niclosamide and albendazole based on solid-phase mechanochemical technology, and to evaluate their efficacy against equine nematodosis and cestodosis. Methods: Novel formulation of antiparasitic paste were prepared using joint mechano-chemical treatment of ivermectin (0.2 mg/kg bodyweight; BW), niclosamide (10 mg/kg BW) and albendazole (3, 5, 10 mg/kg BW) substances with polyvinylpyrrolidone and arabinogalactan. For the evaluation of activity of different doses of formulations against gastrointestinal tract helminths a total of 151 adult horses of the Novoaltai breed weighing 450-500 kg naturally infected with strongyles (>150 egg per gram of faeces, EPG), Results: Pastes with mechanically modified ivermectin showed 91.4-100% efficacy against strongyles and Conclusion: Solid-phase mechanochemical technology could be applied in equine anthelminthics production. It is suggested that future studies focus on plasma concentration-time profile of these highly effective pastes.

Indexed as

AlbendazoleHelminthsHorsesIvermectinMechanochemistryNiclosamide

Identifiers

PMID37197070
PMCPMC10183445
OpenAlexW4362722928

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.